anti-PD-1 antibodies

PD-1 inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-PD-1 antibodies, covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies [Phase 1]